GT Biopharma Quote - GTBP

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.00

Bid

1.80

Offer

3.27

Volume

26,571

2.92 Day's Range 3.10

1.72 52 Week Range 10.6599

Market Cap

6.703M

Previous Close

2.94

Open

3.01

Last Trade

2.97

Last Trade Time

Financial Volume

US$ 80,261

VWAP

3.0206

Average Volume (3m)

407,933

Shares Outstanding

2,234,328

Dividend Yield

PE Ratio

-0.90

Earnings Per Share (EPS)

-3.4

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was US$2.94. Over the last year, GT Biopharma shares have traded in a share price range of US$ 1.72 to US$ 10.6599.

GT Biopharma currently has 2,234,328 shares in issue. The market capitalisation of GT Biopharma is US$6.57 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.90.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.12	-3.84615384615	3.12	3.2	2.612	60427	3.02707739	CS
4	0.55	22.4489795918	2.45	4.1	1.72	1238690	2.81850302	CS
12	1	50	2	4.1	1.72	407933	2.82191985	CS
26	0.28	10.2941176471	2.72	4.1	1.72	189753	2.80593597	CS
52	-4.674	-60.9069585614	7.674	10.6599	1.72	457901	6.22201069	CS
156	-87.3	-96.6777408638	90.3	112.2	1.72	279513	18.97178156	CS
260	-162	-98.1818181818	165	591.993	1.72	315148	101.12260505	CS

GTBP - Frequently Asked Questions (FAQ)

What is the current GT Biopharma share price?

The current share price of GT Biopharma is US$ 3.00

How many GT Biopharma shares are in issue?

GT Biopharma has 2,234,328 shares in issue

What is the market cap of GT Biopharma?

The market capitalisation of GT Biopharma is USD 6.57M

What is the 1 year trading range for GT Biopharma share price?

GT Biopharma has traded in the range of US$ 1.72 to US$ 10.6599 during the past year

What is the PE ratio of GT Biopharma?

The price to earnings ratio of GT Biopharma is -0.9

What is the reporting currency for GT Biopharma?

GT Biopharma reports financial results in USD

What is the latest annual profit for GT Biopharma?

The latest annual profit of GT Biopharma is USD -7.6M

What is the registered address of GT Biopharma?

The registered address for GT Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the GT Biopharma website address?

The website address for GT Biopharma is www.gtbiopharma.com

Which industry sector does GT Biopharma operate in?

GT Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	259.78M
NITON2OFF Inc	US$ 2.6306 (145.85%)	350.92M
CRNCCerence Inc	US$ 19.33 (143.76%)	159.55M
KITTNauticus Robotics Inc	US$ 3.8249 (140.56%)	104.78M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.59M
HWHHWH International Inc	US$ 0.4621 (-28.80%)	7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5.69 (-26.30%)	24.77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5.59 (-23.42%)	161.15k
PTLEPTL Ltd	US$ 9.35 (-23.30%)	1.04M
NXUNXU Inc	US$ 0.725868 (-22.78%)	7.59M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
TGLTreasure Global Inc	US$ 0.382 (101.58%)	337.5M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NVDANVIDIA Corporation	US$ 144.47 (4.45%)	230.01M

Symbol

Price

Vol.